🔎 Trials Near Me

Home › Kanser ng Endometrium › Wisconsin

Pag-aaral pangklinika para sa Kanser ng Endometrium sa Wisconsin

24 pag-aaral para sa Kanser ng Endometrium ang naghahanap ng mga kalahok sa mga site sa Wisconsin.

Mga Lungsod sa Wisconsin

Opisyal na teksto ng pag-aaral (English)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • ThedaCare Regional Cancer Center, Appleton
  • ThedaCare Regional Medical Center - Appleton, Appleton
  • Duluth Clinic Ashland, Ashland
  • at 42 pa
Nagre-recruitPhase 2
Lahat ng edad · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05564377

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

  • Medical College of Wisconsin, Milwaukee
Nagre-recruitPhase 1
Edad 18 pataas · Kababaihan · Na-update Okt 2, 2026 · NCT05950464

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • University of Wisconsin Carbone Cancer Center, Madison
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04585750

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

  • Duluth Clinic Ashland, Ashland
  • Saint Vincent Hospital Cancer Center Green Bay, Green Bay
  • Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay
  • at 8 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Okt 2, 2026 · NCT07198074

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

  • Mayo Clinic Health System - Northwest Wisconsin, Eau Claire
  • Mayo Clinic Health System - Southwest Wisconsin, La Crosse
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Kababaihan · Na-update Set 29, 2026 · NCT05051722

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

  • Duluth Clinic Ashland, Ashland
  • Northwest Wisconsin Cancer Center, Ashland
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Set 28, 2026 · NCT05112601

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

  • Research Site, Milwaukee
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06218914

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

  • Saint Vincent Hospital Cancer Center Green Bay, Green Bay
  • Medical College of Wisconsin, Milwaukee
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Set 24, 2026 · NCT05640999

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

  • Research Site, Madison
Nagre-recruitPhase 2
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT05489211

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  • Froedtert & MCW Cancer Center, Milwaukee
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07109726

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • ThedaCare Regional Cancer Center, Appleton
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT05059444

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

  • Froedtert and Medical College of Wisconsin, Milwaukee
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Ago 21, 2026 · NCT05548296

Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial

  • Froedtert Hospital, Milwaukee
Nagre-recruit
Edad 65 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07227077

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • University of Wisconsin, Carbone Cancer Center, Madison
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05919264

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • University of Wisconsin- Madison, Madison
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05592626

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

  • Research Site, Waukesha
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Hul 29, 2026 · NCT07044336

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

  • 121, Milwaukee
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Hul 16, 2026 · NCT06906341

Study of EV for Recurrent Endometrial Carcinoma

  • Froedtert Memorial Lutheran Hospital, Milwaukee
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Hul 13, 2026 · NCT07139977

Integrated Cancer Repository for Cancer Research

  • Bellin Memorial Hospital, Green Bay
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

  • Wisconsin Institute Medical Research- UW Cancer Connect, Madison
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Hun 2, 2026 · NCT06730347

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

  • Froedtert & the Medical College of Wisconsin, Milwaukee
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2025 · NCT05902988

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Milwaukee
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.